Marked creatine-phosphokinase elevation in myopathy after treatment with bezafibrate

Harefuah

Volumn 139, Issue 5-6, 2000, Pages 193-195+246

  Slobodin, G ^a   Yeshurun, D ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; CREATINE KINASE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; METFORMIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; WARFARIN;

ADULT; ARTICLE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; HUMAN; KIDNEY FAILURE; LIPOPROTEIN BLOOD LEVEL; MYOPATHY; MYOSITIS; PERITONEAL DIALYSIS; RHABDOMYOLYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTILIPEMIC AGENTS; BEZAFIBRATE; CREATINE KINASE; FEMALE; HUMANS; HYPERLIPIDEMIAS; MIDDLE AGED; MYOSITIS;

EID: 0033759192     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Drug treatment of hyperlipidemias at the end of the millenium
2. Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease
3. Benzafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidemia
4. Transcriptional control of triglyceride metabolism: Fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR
5. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
6. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)
7. Clofibrate myopathy: A case report and review of the literature
8. Bezafibrate induced rhabdomyolisis
9. Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient. Letter
10. Acute severe myositis as a complication of bezafibrate treatment
11. A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate
12. Clinical pharmacokinetics of fibric acid derivatives (fibrates)